Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / EGFR変異型NSCLC患者由来オルガノイドにおける標的療法に対する感受性のプロファイリング…
JoVE Journal
Cancer Research

This content is Free Access.

JoVE Journal Cancer Research
EGFR変異型NSCLC患者由来オルガノイドにおける標的療法に対する感受性のプロファイリング
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Journal (Cancer Research)
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Journal (Cancer Research)
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
 
Click here for the English version

EGFR変異型NSCLC患者由来オルガノイドにおける標的療法に対する感受性のプロファイリング

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

このプロトコールは、NSCLC患者由来オルガノイドモデルにおける標的シグナル伝達阻害剤に対する薬物感受性の標準化された評価を記載している。

Tags

がん研究 オルガノイド 肺オルガノイド PDO NSCLC 肺癌 オシメルチニブ EGFR 標的阻害剤 抵抗性
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter